Matches in SemOpenAlex for { <https://semopenalex.org/work/W1516601417> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W1516601417 endingPage "222" @default.
- W1516601417 startingPage "219" @default.
- W1516601417 abstract "Vitiligo progression is attributed to immune system malfunctioning, thus immunomodulating compounds might be beneficial in stopping vitiligo progression which is a prerequisite for successful repigmentation. The goal of this study was to assess efficacy of acridone acetic acid, sodium salt (Na-AAA), an immunomodulating compound with favorable safety profile, in stabilizing active vitiligo, and to reveal prognostic factors of treatment outcome. Sixty consecutive patients with progressing nonsegmental vitiligo were treated with 10 i.m. injections of Na-AAA every other day. Disease stability was assessed in 1, 3, 6, and 12 months post-treatment. Statistical analysis was applied to correlate treatment outcome and available clinical parameters. Of the 60 patients treated, vitiligo stopped progression in 44 patients (73.3%). Older age (p = 0.0219), age of 35 and older (p = 0.0189, odds ratio (OR) = 5.2, 95% confidence interval (CI) 1.30-20.84) or age of 40 and older (p = 0.0039, OR = 6.48, 95% CI 1.86-22.61), longer disease duration (p = 0.0234), pre-treatment interleukin-6 level over 2 pg/mL (p = 0.0005, OR = 13.7, 95% CI 2.97-63), and over the reference threshold value 5.9 pg/mL (p = 0.0009, OR = 25.8, 95% CI 2.8-239) as well as presence of other autoimmune diseases (p = 0.038, OR = 7.0, 95% CI 1.14-42.97) were negative prognostic factors of treatment success. In conclusion, acridone acetic acid, sodium salt, emerges as an efficient option for stopping vitiligo progression." @default.
- W1516601417 created "2016-06-24" @default.
- W1516601417 creator A5054219000 @default.
- W1516601417 creator A5076780193 @default.
- W1516601417 date "2014-02-18" @default.
- W1516601417 modified "2023-10-10" @default.
- W1516601417 title "Acridone acetic acid, sodium salt, as an agent to stop vitiligo progression: a pilot study" @default.
- W1516601417 cites W1521858627 @default.
- W1516601417 cites W1597383179 @default.
- W1516601417 cites W1608140060 @default.
- W1516601417 cites W1972297621 @default.
- W1516601417 cites W2012231950 @default.
- W1516601417 cites W2052234755 @default.
- W1516601417 cites W2055539585 @default.
- W1516601417 cites W2169239586 @default.
- W1516601417 cites W4205890351 @default.
- W1516601417 doi "https://doi.org/10.1111/dth.12121" @default.
- W1516601417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24548590" @default.
- W1516601417 hasPublicationYear "2014" @default.
- W1516601417 type Work @default.
- W1516601417 sameAs 1516601417 @default.
- W1516601417 citedByCount "5" @default.
- W1516601417 countsByYear W15166014172018 @default.
- W1516601417 countsByYear W15166014172020 @default.
- W1516601417 crossrefType "journal-article" @default.
- W1516601417 hasAuthorship W1516601417A5054219000 @default.
- W1516601417 hasAuthorship W1516601417A5076780193 @default.
- W1516601417 hasConcept C126322002 @default.
- W1516601417 hasConcept C156957248 @default.
- W1516601417 hasConcept C16005928 @default.
- W1516601417 hasConcept C185592680 @default.
- W1516601417 hasConcept C2776673659 @default.
- W1516601417 hasConcept C2777482282 @default.
- W1516601417 hasConcept C2779980618 @default.
- W1516601417 hasConcept C44249647 @default.
- W1516601417 hasConcept C55493867 @default.
- W1516601417 hasConcept C71240020 @default.
- W1516601417 hasConcept C71924100 @default.
- W1516601417 hasConcept C90924648 @default.
- W1516601417 hasConceptScore W1516601417C126322002 @default.
- W1516601417 hasConceptScore W1516601417C156957248 @default.
- W1516601417 hasConceptScore W1516601417C16005928 @default.
- W1516601417 hasConceptScore W1516601417C185592680 @default.
- W1516601417 hasConceptScore W1516601417C2776673659 @default.
- W1516601417 hasConceptScore W1516601417C2777482282 @default.
- W1516601417 hasConceptScore W1516601417C2779980618 @default.
- W1516601417 hasConceptScore W1516601417C44249647 @default.
- W1516601417 hasConceptScore W1516601417C55493867 @default.
- W1516601417 hasConceptScore W1516601417C71240020 @default.
- W1516601417 hasConceptScore W1516601417C71924100 @default.
- W1516601417 hasConceptScore W1516601417C90924648 @default.
- W1516601417 hasIssue "4" @default.
- W1516601417 hasLocation W15166014171 @default.
- W1516601417 hasLocation W15166014172 @default.
- W1516601417 hasOpenAccess W1516601417 @default.
- W1516601417 hasPrimaryLocation W15166014171 @default.
- W1516601417 hasRelatedWork W1843463370 @default.
- W1516601417 hasRelatedWork W1982619745 @default.
- W1516601417 hasRelatedWork W2002325000 @default.
- W1516601417 hasRelatedWork W2011867183 @default.
- W1516601417 hasRelatedWork W2076929529 @default.
- W1516601417 hasRelatedWork W2114056959 @default.
- W1516601417 hasRelatedWork W2417545465 @default.
- W1516601417 hasRelatedWork W2996661745 @default.
- W1516601417 hasRelatedWork W2999586795 @default.
- W1516601417 hasRelatedWork W4225673987 @default.
- W1516601417 hasVolume "27" @default.
- W1516601417 isParatext "false" @default.
- W1516601417 isRetracted "false" @default.
- W1516601417 magId "1516601417" @default.
- W1516601417 workType "article" @default.